#clinical trials

Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C ...

- Today ChanTest announces the hiring of Chris Mathes, Ph.D., M.B.A. to lead its business into a new era. Mathes starts ...

- Takeda Global Research and Development Asia, Pte. Ltd. ("TGRD (Asia)") and Takeda Shanghai Development Center ...

- PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that the French ...

-     Berg Pharma, a Boston-based pharmaceutical company and the renowned Parkinson's Institute ...

-         CROMSOURCE, an international full service contract research organisation ...

-     Stiefel, a GSK (NYSE:GSK) company, and Welichem Biotech, Inc. (WBI:CN), have entered into an ...

Academia Sinica President Chi-Huey Wong, a world leader in carbohydrate chemistry, was awarded the Nikkei Asia Prize ...

-Study Results Will be Used to Support PMA Application for the RePneu LVRC System     PneumRx, Inc. ...

-         Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life ...

-     PEIpro(TM) further expands an already rich catalogue of innovative ...

-     Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that Dr. Daniel G. Chain, chairman and ...

Transplanting stem cells into the brains of people with Parkinson`s disease could one day replace medication as the ...

-Commercial rights to HYALGAN transitioned from Sanofi back to Fidia, the brand's owner and manufacturerWholly-owned ...

-         Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company ...